Therapeutic ultrasound versus injection of local anesthetic in the treatment of women with chronic pelvic pain secondary to abdominal myofascial syndrome: a randomized clinical trial

Chronic pelvic pain (CPP) is defined as recurrent or continuous pain in the lower abdomen or pelvis, either non-menstrual or noncyclical, lasting for at least 6 months. There is strong evidence that up to 85% of patients with CPP have serious dysfunctions of the musculoskeletal system, including abd...

Full description

Saved in:

Bibliographic Details
Published in:	BMC women's health Vol. 22; no. 1; pp. 325 - 11
Main Authors:	Baltazar, Maria Carolina Dalla Vecchia, Russo, Jéssica Aparecida de Oliveira, De Lucca, Victória, Mitidieri, Andréia Moreira de Souza, da Silva, Ana Paula Moreira, Gurian, Maria Beatriz Ferreira, Poli-Neto, Omero Benedicto, Rosa-E-Silva, Júlio César
Format:	Journal Article
Language:	English
Published:	England BioMed Central Ltd 02-08-2022 BioMed Central BMC
Subjects:	Abdomen Analgesics Anesthetics Anesthetics, Local - therapeutic use Anti-inflammatory agents Antidepressants Care and treatment Chronic Pain - etiology Chronic Pain - therapy Clinical trials Comparative analysis Complications and side effects COVID-19 Demographic aspects Dosage and administration Female Humans Injection Local anesthesia Musculoskeletal system Myofascial pain syndrome Myofascial Pain Syndromes - drug therapy Myofascial Pain Syndromes - therapy Nonsteroidal anti-inflammatory drugs Outpatient care facilities Pain Patient outcomes Pelvic pain Pelvic Pain - drug therapy Pelvic Pain - therapy Performance evaluation Quality of Life Questionnaires Treatment Outcome Ultrasonic imaging Ultrasonic therapy Ultrasonics in medicine Womens health Brazil Ultrasonic therapy Myofascial pain syndrome Pelvic pain Local anesthesia
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Chronic pelvic pain (CPP) is defined as recurrent or continuous pain in the lower abdomen or pelvis, either non-menstrual or noncyclical, lasting for at least 6 months. There is strong evidence that up to 85% of patients with CPP have serious dysfunctions of the musculoskeletal system, including abdominal myofascial pain syndrome (AMPS). AMPS is characterized by intense and deep abdominal pain, originating from hyperirritable trigger points, usually located within a musculoskeletal band or its lining fascia. In the literature, there are few studies that address AMPS. To evaluate and compare the efficacy of therapeutic ultrasound (TUS) and injection of local anesthetic (IA) to improve pain in women with abdominal myofascial syndrome secondary to CPP. Randomized controlled clinical trial. Tertiary University Hospital. A randomized clinical trial was conducted, patients were allocated to two types of treatment: group TUS (n = 18), and group IA (n = 20). The instruments used for evaluation and reassessment were the Visual Analog Scale, Numerical Categorical Scale, McGill Pain Questionnaire, and SF-36 quality of life assessment questionnaire. They were evaluated before starting treatment, 1 week after the end of treatment, and at 1, 3, and 6 months. TUS and IA were effective in reducing clinical pain and improving quality of life through the variables analyzed among study participants. There was no significant difference between groups. absence of blinding; exclusion of women with comorbidities and other causes of CPP, the absence of a placebo group, the difference between the number of sessions used for each technique, and the COVID-19. Treatment with TUS and IA were effective in reducing clinical pain and improving quality of life in women with AMPS secondary to CPP. We declare that this clinical trial has been registered under the number [(ReBEC) no. RBR-39czsv] on 07/18/2018 in the Brazilian Registry of Clinical Trials.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3
ISSN:	1472-6874 1472-6874
DOI:	10.1186/s12905-022-01910-y